Admiron Life Sciences Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 42.39 Cr
as on 06-07-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.44 Cr
as on 06-07-2024
- Satisfied Charges ₹ 98.25 Cr
as on 06-07-2024
- Revenue 90.39%
(FY 2022)
- Profit 27.70%
(FY 2022)
- Ebitda 175.77%
(FY 2022)
- Net Worth -5.58%
(FY 2022)
- Total Assets 24.74%
(FY 2022)
About Admiron Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 42.39 Cr.
The company currently has active open charges totaling ₹16.44 Cr. The company has closed loans amounting to ₹98.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sainadh Thatiparthi, Kanigiri Gade, and Govinda Balineni serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC071534
- Company No.
071534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Shaikpet, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Admiron Life Sciences Private Limited offer?
Admiron Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Admiron Life Sciences?
Board Members(3)
Financial Performance and Corporate Structure Insights of Admiron Life Sciences.
Admiron Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 90.39% increase. The company also saw a substantial improvement in profitability, with a 27.7% increase in profit. The company's net worth dipped by a decrease of 5.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Admiron Life Sciences?
In 2019, Admiron Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pranaya Life Sciences Private Limited
Active
6 years 6 months Sainadh Thatiparthi, Kanigiri Gade and 1 more are mutual person
Pranaya Pharmaceuticals Private Limited
Active 4 years 6 months Kanigiri Gade and Govinda Balineni are mutual person
Aarishi Medkare Private Limited
Active 7 years 7 months Sainadh Thatiparthi, Kanigiri Gade and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 May 2021 | ₹16.25 Cr | Open |
Others Creation Date: 31 Dec 2020 | ₹1.87 M | Open |
State Bank Of Hyderabad Creation Date: 24 Dec 2013 | ₹59.25 Cr | Satisfied |
How Many Employees Work at Admiron Life Sciences?
Admiron Life Sciences has a workforce of 124 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of May 26, 2015, Admiron Life Sciences has raised a total of ₹ 42.38 Cr, with the most recent deal valued at ₹ 6.35 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
